B3galnt2 | UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 2
Physiological systems
19 / 24 physiological systems tested
5 Significantly impacted by the knock-out
Embryo Growth/size/body region Behavior/neurological Skeleton Mortality/aging
14 No significant impact
5 Not tested
Data collections
Gene metrics:4Significant phenotypes
4Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
| decreased bone mineral content | 1 supporting dataset | B3galnt2em1(IMPC)J | heterozygote | Early adult | 9.49x10-5 | ||
| abnormal embryo size | 1 supporting dataset | B3galnt2em1(IMPC)J | homozygote | E18.5 | N/A * | ||
| preweaning lethality, complete penetrance | 1 supporting dataset | B3galnt2em1(IMPC)J | homozygote | Early adult | N/A * | ||
| abnormal locomotor behavior | 1 supporting dataset | B3galnt2em1(IMPC)J | heterozygote | Late adult | 1.56x10-5 |
| | | | | | | | | | |
External links
No external links available for B3galnt2.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
| B3galnt2em1(IMPC)J | Exon Deletion | | mouse |
| B3galnt2tm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
| B3galnt2tm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |